Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 7.02 USD Market Closed
Market Cap: $575.6m

Relative Value

The Relative Value of one ACCD stock under the Base Case scenario is hidden USD. Compared to the current market price of 7.02 USD, Accolade Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACCD Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

ACCD Competitors Multiples
Accolade Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Accolade Inc
NASDAQ:ACCD
569.9m USD 1.3 -3.2 -12.6 -6.4
US
CVS Health Corp
NYSE:CVS
96.2B USD 0.2 54.4 13.9 13.9
US
Cigna Group
XMUN:CGN
66B EUR 0.3 12.9 7.6 9.6
US
Cigna Corp
NYSE:CI
68.7B USD 0.3 11.5 0 0
DE
Fresenius SE & Co KGaA
XETRA:FRE
26.4B EUR 1.2 20.8 9.8 14.6
DE
Fresenius Medical Care AG
XMUN:FME
23.1B EUR 1.2 23.6 9.1 16.8
US
Laboratory Corporation of America Holdings
NYSE:LH
22.2B USD 1.6 25.3 12.2 17.7
US
Quest Diagnostics Inc
NYSE:DGX
22.1B USD 2 22.4 12.4 16.8
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11B EUR 0.6 11.3 5.4 10
US
Guardant Health Inc
NASDAQ:GH
11.5B USD 11.7 -27.6 -29.7 -27
US
DaVita Inc
NYSE:DVA
10.6B USD 0.8 14.2 7.4 10
P/E Multiple
Earnings Growth PEG
US
Accolade Inc
NASDAQ:ACCD
Average P/E: 21.8
Negative Multiple: -3.2
N/A N/A
US
CVS Health Corp
NYSE:CVS
54.4
90%
0.6
US
C
Cigna Group
XMUN:CGN
12.9
19%
0.7
US
Cigna Corp
NYSE:CI
11.5
19%
0.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
20.8
26%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
23.6
16%
1.5
US
Laboratory Corporation of America Holdings
NYSE:LH
25.3
27%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
22.4
12%
1.9
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.3
16%
0.7
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -27.6 N/A N/A
US
DaVita Inc
NYSE:DVA
14.2
21%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Accolade Inc
NASDAQ:ACCD
Average EV/EBITDA: 9.7
Negative Multiple: -12.6
N/A N/A
US
CVS Health Corp
NYSE:CVS
13.9
28%
0.5
US
C
Cigna Group
XMUN:CGN
7.6
4%
1.9
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
DE
Fresenius SE & Co KGaA
XETRA:FRE
9.8
10%
1
DE
Fresenius Medical Care AG
XMUN:FME
9.1
7%
1.3
US
Laboratory Corporation of America Holdings
NYSE:LH
12.2
10%
1.2
US
Quest Diagnostics Inc
NYSE:DGX
12.4
7%
1.8
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
5.4
7%
0.8
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -29.7 N/A N/A
US
DaVita Inc
NYSE:DVA
7.4
4%
1.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Accolade Inc
NASDAQ:ACCD
Average EV/EBIT: 13.7
Negative Multiple: -6.4
N/A N/A
US
CVS Health Corp
NYSE:CVS
13.9
22%
0.6
US
C
Cigna Group
XMUN:CGN
9.6
6%
1.6
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
DE
Fresenius SE & Co KGaA
XETRA:FRE
14.6
13%
1.1
DE
Fresenius Medical Care AG
XMUN:FME
16.8
17%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
17.7
18%
1
US
Quest Diagnostics Inc
NYSE:DGX
16.8
10%
1.7
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10
17%
0.6
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -27 N/A N/A
US
DaVita Inc
NYSE:DVA
10
5%
2
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett